Syngene International P/E Ratio
Syngene International (SYNGENE) P/E ratio is 69.95 (High), EPS (TTM) ₹7.87, current price ₹369.05 on NSE vs historical average P/E of 50.72 (87.5th percentile) — Very High - High growth expectations or significantly overvalued.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SYNGENE P/E Ratio — Valuation Signal & Historical Context
Syngene International P/E 69.95 vs historical average 50.72, range 19.89–100.37 — signal: Overvalued. Also explore Syngene International stock price data download to track price trends across different timeframes.
- Stock appears overvalued with PE of 69.95, suggesting caution for new investments
- Current PE is 37.9% above historical average
- Trading at premium to sector average PE of 56.73
Syngene International P/E Ratio Historical Trend
SYNGENE annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 69.95 vs historical average 50.72. For live price, revenue and the complete fundamental profile, see SYNGENE stock price BSE.
SYNGENE Historical P/E Ratio — EPS, Year-End Price & Valuation
Syngene International annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 100.37 | 8.76 | ₹879.25 | NSE | High |
| 2024 | 56.78 | 12.5 | ₹709.75 | NSE | High |
| 2023 | 46.87 | 12.37 | ₹579.75 | NSE | High |
| 2022 | 56.41 | 10.85 | ₹612.00 | NSE | High |
| 2021 | 62.24 | 10.16 | ₹632.35 | NSE | High |
| 2020 | 35.07 | 9.19 | ₹322.30 | NSE | High |
| 2019 | 28.15 | 9.9 | ₹278.70 | NSE | High |
| 2018 | 19.89 | 13.77 | ₹273.90 | NSE | Moderate |
SYNGENE vs Healthcare Peers — P/E Ratio Comparison
Syngene International P/E 69.95 vs Healthcare average 56.73, median 31.66 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |